TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2012-11, Vol.56 (11), p.5476-5483 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5483 |
---|---|
container_issue | 11 |
container_start_page | 5476 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 56 |
creator | STRYJEWSKI, Martin E POTGIETER, Peter D LI, Yu-Ping BARRIERE, Steven L CHURUKIAN, Allan KINGSLEY, Jeff COREY, G. Ralph |
description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
doi_str_mv | 10.1128/AAC.00712-12 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1237508576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1237508576</sourcerecordid><originalsourceid>FETCH-LOGICAL-a475t-440cd3ef23ef9bc754c34feac150b7b34f7b6bd7568dc3d2b8a6b6c4c2b4f4b03</originalsourceid><addsrcrecordid>eNp1kUuLFDEUhYMoTtu6cy2FIChYY5LKo2ojNO1rYMDFtIKrcJNKpjNWJT1J1cj8e9N2O-rCRci95Mu5OTkIPSX4lBDavlmt1qcYS0JrQu-hBcFdWwveiftogbEQNWsxO0GPcr7CpecdfohOKG1FxyVZoG-bdzWRHa1ubMpzrr5CMHG8NT5ULqZqkyxMow1TFV21juNu8AYm21cX3wsB4VhcTGk205xsdRacNZOPIT9GDxwM2T457kv05cP7zfpTff7549l6dV4Dk3yqGcOmb6yjZXXaSM5Mw5wFQzjWUpdaaqF7yUXbm6anugWhhWGGauaYxs0SvT3o7mY92t6UxyYY1C75EdKtiuDVvyfBb9VlvFENawVne4GXR4EUr2ebJzX6bOwwQLBxzorQRnLccikK-vqAmhRzTtbdjSFY7dNQJQ31K439tSV6dcAhj1RdxTmF8hP_Y5_9beNO-HdUBXhxBCAbGFwqSfn8hyteOBOycM8P3NZfbn_4ZFWZrgCM4qLMVZwVIz8BQN2q2Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237508576</pqid></control><display><type>article</type><title>TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>STRYJEWSKI, Martin E ; POTGIETER, Peter D ; LI, Yu-Ping ; BARRIERE, Steven L ; CHURUKIAN, Allan ; KINGSLEY, Jeff ; COREY, G. Ralph</creator><creatorcontrib>STRYJEWSKI, Martin E ; POTGIETER, Peter D ; LI, Yu-Ping ; BARRIERE, Steven L ; CHURUKIAN, Allan ; KINGSLEY, Jeff ; COREY, G. Ralph ; TD-1792 Investigators Group ; for the TD-1792 Investigators Group</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00712-12</identifier><identifier>PMID: 22869571</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Bacterial Agents ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cephalosporins ; Cephalosporins - pharmacology ; Cephalosporins - therapeutic use ; Double-Blind Method ; Drug Administration Schedule ; Experimental Therapeutics ; Female ; Glycopeptides ; Glycopeptides - pharmacology ; Glycopeptides - therapeutic use ; Humans ; Injections, Intravenous ; Male ; Medical sciences ; Methicillin-Resistant Staphylococcus aureus ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - growth & development ; Middle Aged ; Pharmacology. Drug treatments ; Skin ; Skin - drug effects ; Skin - microbiology ; Skin Diseases, Bacterial ; Skin Diseases, Bacterial - drug therapy ; Skin Diseases, Bacterial - microbiology ; Staphylococcal Infections ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - microbiology ; Vancomycin ; Vancomycin - pharmacology ; Vancomycin - therapeutic use</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5476-5483</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a475t-440cd3ef23ef9bc754c34feac150b7b34f7b6bd7568dc3d2b8a6b6c4c2b4f4b03</citedby><cites>FETCH-LOGICAL-a475t-440cd3ef23ef9bc754c34feac150b7b34f7b6bd7568dc3d2b8a6b6c4c2b4f4b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486540/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486540/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,729,782,786,887,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26545467$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22869571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STRYJEWSKI, Martin E</creatorcontrib><creatorcontrib>POTGIETER, Peter D</creatorcontrib><creatorcontrib>LI, Yu-Ping</creatorcontrib><creatorcontrib>BARRIERE, Steven L</creatorcontrib><creatorcontrib>CHURUKIAN, Allan</creatorcontrib><creatorcontrib>KINGSLEY, Jeff</creatorcontrib><creatorcontrib>COREY, G. Ralph</creatorcontrib><creatorcontrib>TD-1792 Investigators Group</creatorcontrib><creatorcontrib>for the TD-1792 Investigators Group</creatorcontrib><title>TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cephalosporins</subject><subject>Cephalosporins - pharmacology</subject><subject>Cephalosporins - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Drug Administration Schedule</subject><subject>Experimental Therapeutics</subject><subject>Female</subject><subject>Glycopeptides</subject><subject>Glycopeptides - pharmacology</subject><subject>Glycopeptides - therapeutic use</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Methicillin-Resistant Staphylococcus aureus - drug effects</subject><subject>Methicillin-Resistant Staphylococcus aureus - growth & development</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Skin</subject><subject>Skin - drug effects</subject><subject>Skin - microbiology</subject><subject>Skin Diseases, Bacterial</subject><subject>Skin Diseases, Bacterial - drug therapy</subject><subject>Skin Diseases, Bacterial - microbiology</subject><subject>Staphylococcal Infections</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Vancomycin</subject><subject>Vancomycin - pharmacology</subject><subject>Vancomycin - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUuLFDEUhYMoTtu6cy2FIChYY5LKo2ojNO1rYMDFtIKrcJNKpjNWJT1J1cj8e9N2O-rCRci95Mu5OTkIPSX4lBDavlmt1qcYS0JrQu-hBcFdWwveiftogbEQNWsxO0GPcr7CpecdfohOKG1FxyVZoG-bdzWRHa1ubMpzrr5CMHG8NT5ULqZqkyxMow1TFV21juNu8AYm21cX3wsB4VhcTGk205xsdRacNZOPIT9GDxwM2T457kv05cP7zfpTff7549l6dV4Dk3yqGcOmb6yjZXXaSM5Mw5wFQzjWUpdaaqF7yUXbm6anugWhhWGGauaYxs0SvT3o7mY92t6UxyYY1C75EdKtiuDVvyfBb9VlvFENawVne4GXR4EUr2ebJzX6bOwwQLBxzorQRnLccikK-vqAmhRzTtbdjSFY7dNQJQ31K439tSV6dcAhj1RdxTmF8hP_Y5_9beNO-HdUBXhxBCAbGFwqSfn8hyteOBOycM8P3NZfbn_4ZFWZrgCM4qLMVZwVIz8BQN2q2Q</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>STRYJEWSKI, Martin E</creator><creator>POTGIETER, Peter D</creator><creator>LI, Yu-Ping</creator><creator>BARRIERE, Steven L</creator><creator>CHURUKIAN, Allan</creator><creator>KINGSLEY, Jeff</creator><creator>COREY, G. Ralph</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20121101</creationdate><title>TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections</title><author>STRYJEWSKI, Martin E ; POTGIETER, Peter D ; LI, Yu-Ping ; BARRIERE, Steven L ; CHURUKIAN, Allan ; KINGSLEY, Jeff ; COREY, G. Ralph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a475t-440cd3ef23ef9bc754c34feac150b7b34f7b6bd7568dc3d2b8a6b6c4c2b4f4b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cephalosporins</topic><topic>Cephalosporins - pharmacology</topic><topic>Cephalosporins - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Drug Administration Schedule</topic><topic>Experimental Therapeutics</topic><topic>Female</topic><topic>Glycopeptides</topic><topic>Glycopeptides - pharmacology</topic><topic>Glycopeptides - therapeutic use</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Methicillin-Resistant Staphylococcus aureus - drug effects</topic><topic>Methicillin-Resistant Staphylococcus aureus - growth & development</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Skin</topic><topic>Skin - drug effects</topic><topic>Skin - microbiology</topic><topic>Skin Diseases, Bacterial</topic><topic>Skin Diseases, Bacterial - drug therapy</topic><topic>Skin Diseases, Bacterial - microbiology</topic><topic>Staphylococcal Infections</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Vancomycin</topic><topic>Vancomycin - pharmacology</topic><topic>Vancomycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STRYJEWSKI, Martin E</creatorcontrib><creatorcontrib>POTGIETER, Peter D</creatorcontrib><creatorcontrib>LI, Yu-Ping</creatorcontrib><creatorcontrib>BARRIERE, Steven L</creatorcontrib><creatorcontrib>CHURUKIAN, Allan</creatorcontrib><creatorcontrib>KINGSLEY, Jeff</creatorcontrib><creatorcontrib>COREY, G. Ralph</creatorcontrib><creatorcontrib>TD-1792 Investigators Group</creatorcontrib><creatorcontrib>for the TD-1792 Investigators Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STRYJEWSKI, Martin E</au><au>POTGIETER, Peter D</au><au>LI, Yu-Ping</au><au>BARRIERE, Steven L</au><au>CHURUKIAN, Allan</au><au>KINGSLEY, Jeff</au><au>COREY, G. Ralph</au><aucorp>TD-1792 Investigators Group</aucorp><aucorp>for the TD-1792 Investigators Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>56</volume><issue>11</issue><spage>5476</spage><epage>5483</epage><pages>5476-5483</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22869571</pmid><doi>10.1128/AAC.00712-12</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5476-5483 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_proquest_miscellaneous_1237508576 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Adolescent Adult Aged Anti-Bacterial Agents Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cephalosporins Cephalosporins - pharmacology Cephalosporins - therapeutic use Double-Blind Method Drug Administration Schedule Experimental Therapeutics Female Glycopeptides Glycopeptides - pharmacology Glycopeptides - therapeutic use Humans Injections, Intravenous Male Medical sciences Methicillin-Resistant Staphylococcus aureus Methicillin-Resistant Staphylococcus aureus - drug effects Methicillin-Resistant Staphylococcus aureus - growth & development Middle Aged Pharmacology. Drug treatments Skin Skin - drug effects Skin - microbiology Skin Diseases, Bacterial Skin Diseases, Bacterial - drug therapy Skin Diseases, Bacterial - microbiology Staphylococcal Infections Staphylococcal Infections - drug therapy Staphylococcal Infections - microbiology Vancomycin Vancomycin - pharmacology Vancomycin - therapeutic use |
title | TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T01%3A48%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TD-1792%20versus%20Vancomycin%20for%20Treatment%20of%20Complicated%20Skin%20and%20Skin%20Structure%20Infections&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=STRYJEWSKI,%20Martin%20E&rft.aucorp=TD-1792%20Investigators%20Group&rft.date=2012-11-01&rft.volume=56&rft.issue=11&rft.spage=5476&rft.epage=5483&rft.pages=5476-5483&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.00712-12&rft_dat=%3Cproquest_cross%3E1237508576%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237508576&rft_id=info:pmid/22869571&rfr_iscdi=true |